THE EFFECT OF RANITIDINE ON POSTOPERATIVE INFECTIOUS COMPLICATIONS FOLLOWING EMERGENCY COLORECTAL SURGERY - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
F. Moesgaard et al., THE EFFECT OF RANITIDINE ON POSTOPERATIVE INFECTIOUS COMPLICATIONS FOLLOWING EMERGENCY COLORECTAL SURGERY - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL, Inflammation research, 47(1), 1998, pp. 12-17
Objective and Design: To study the potential effect of ranitidine on p
ostoperative infectious complications following emergency colorectal s
urgery. A randomized, placebo-controlled, double-blind trial was carri
ed out in three university clinics and two county hospitals in Denmark
. Patients and Treatment: One hundred and ninety-four consecutive pati
ents undergoing acute colorectal surgery for perforated and/or obstruc
ted large bowel were randomized in a double-blind fashion to receive r
anitidine 100 mg i.v. twice a day commencing at induction of anesthesi
a and continued for five days (group I) or i.v. placebo (group II). Al
l patients were given 1.5g metronidazole plus 3.0g cefuroxime at the t
ime of surgery. Patients with perforation of the colon or rectum were
given metronidazole and cefuroxime for further 3 days. All patients we
re assessed daily until discharge from the hospital. Thirty patients w
ere withdrawn from the study (for reasons such as other diagnosis, ref
used to continue, medication not given as prescribed). Main Outcome Me
asures: Patients were observed ibr signs of infectious complications;
such as wound infection, intraabdominal abscess, septicemia, and pneum
onia. Results: Both groups were similar with respect to age, sex, weig
ht, duration of surgery, blood transfusions, and site of the procedure
, as well as the histologic nature of the underlying disease process.
However, the Mannheim Peritonitis Index (MPI) was significantly higher
in group I compared with group II (p < 0.05), Wound infection, intraa
bdominal abscess, septicemia, and pneumonia were 12.9%, 5.2%, 3.8% and
14%, respectively in group I. In group II, the infectious complicatio
ns were 16.1%, 6.8%, 6.9% and 22%, respectively. Twelve patients (13.8
%) in the placebo group developed mure than one complication compared
with 5 patients (6.5%) in the ranitidine group. Conclusion: Ranitidine
may have a beneficial effect on postoperative infectious complication
s in patients following acute colorectal surgery.